| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
2,274 |
1,894 |
$200K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
709 |
637 |
$92K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
988 |
849 |
$33K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
827 |
621 |
$6K |
| 71046 |
Radiologic examination, chest; 2 views |
1,067 |
958 |
$5K |
| 80053 |
Comprehensive metabolic panel |
3,149 |
2,401 |
$2K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
433 |
401 |
$2K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
3,451 |
2,560 |
$2K |
| 84484 |
|
1,193 |
969 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
54 |
42 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
932 |
802 |
$1K |
| 83690 |
|
202 |
180 |
$697.59 |
| 70450 |
Computed tomography, head or brain; without contrast material |
239 |
220 |
$522.97 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
109 |
78 |
$419.07 |
| 81001 |
|
1,126 |
986 |
$293.18 |
| 85610 |
|
291 |
252 |
$219.20 |
| 83735 |
|
1,356 |
1,060 |
$159.28 |
| 82962 |
|
43 |
30 |
$142.45 |
| 84443 |
Thyroid stimulating hormone (TSH) |
113 |
94 |
$115.31 |
| 83880 |
|
161 |
148 |
$111.22 |
| 82550 |
|
219 |
183 |
$110.48 |
| 85730 |
|
205 |
183 |
$88.70 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
15 |
13 |
$49.95 |
| 81003 |
|
64 |
60 |
$23.96 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
566 |
451 |
$14.76 |
| 82948 |
|
79 |
39 |
$11.46 |
| 80050 |
General health panel |
15 |
14 |
$11.08 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
65 |
61 |
$1.17 |
| 71045 |
Radiologic examination, chest; single view |
204 |
180 |
$0.00 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
63 |
56 |
$0.00 |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
35 |
32 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
41 |
33 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
12 |
12 |
$0.00 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
13 |
13 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
371 |
311 |
$0.00 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
29 |
26 |
$0.00 |
| 80061 |
Lipid panel |
194 |
167 |
$0.00 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
14 |
13 |
$0.00 |